Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: A single-center, double-blind, randomized controlled trial
BMC Anesthesiology Apr 12, 2019
Wang G, et al. - In 120 patients undergoing orthotopic heart transplantation, researchers determined if remote ischemic preconditioning (RIPC) combined with remote ischemic postconditioning (RIPostC) attenuates myocardial injury to donor hearts. In a random manner, a total of 60 participants were assigned to an RIPC+RIPostC group and 60 to a control group. They applied four cycles of 5-min of ischemia and 5-min of reperfusion to the right upper limb by a cuff inflated to 200 mmHg (RIPC) and 20 min following aortic declamping (RIPostC) in the RIPC+RIPostC group. A comparison of serum cardiac troponin I (cTnI) levels at 6 h following aortic declamping was considered as primary endpoint. They found that RIPC combined with RIPostC attenuated myocardial injury at 6 h post-aortic declamping, while no improvement of clinical outcomes due to this function was seen.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries